Home › Funds › Royce & Associates › INBX
Royce & Associates position in INBX
INHIBRX BIOSCIENCES INC · Health Care
Latest position (Q4 2023)12.99K sh
Reported value held$493.81K
Portfolio Weight0.00%
First reportedQ4 2023
Last changeNew
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 12.99K | $493.81K | New |
Other funds holding INBX
- Morgan Stanley 1.31M sh · $123.94M · Q2 2026
- Viking Global Investors 1.12M sh · $106.49M · Q2 2026
- Bank of America Corp 841.14K sh · $79.70M · Q2 2026
- BlackRock Inc 825.97K sh · $78.26M · Q2 2026
- Vanguard Group 623.08K sh · $49.22M · Q4 2025
- Capital Research Global Investors 363.05K sh · $34.40M · Q2 2026
- Geode Capital Management 256.18K sh · $24.28M · Q2 2026
- Millennium Management 147.20K sh · $13.95M · Q2 2026
- Northern Trust Corp 100.96K sh · $9.57M · Q2 2026
- Norges Bank Investment Management 90.30K sh · $8.56M · Q2 2026
- Citigroup Inc 75.72K sh · $7.17M · Q2 2026
- Goldman Sachs Group 66.50K sh · $6.30M · Q2 2026